Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
08/1998
08/12/1998CN1190349A Viral agent associated with mystery swine disease
08/12/1998CN1190128A Transgenic virus
08/12/1998CA2223029A1 Canine parvovirus dna vaccines
08/11/1998US5792643 Cooling an aqueous suspension of virus, saccharide, high-molecular-weight structural additive, an amino acid and buffer and freeze drying maintaining 10% water; gene therapy
08/11/1998US5792462 Alphavirus RNA replicon systems
08/11/1998US5792452 Live salmonella vaccine having an increased stability
08/06/1998WO1998033928A1 Live recombinant avian vaccine using the avian infectious laryngotracheitis virus as vector
08/06/1998WO1998033892A1 Establishment of hhv-8+ lymphoma cell line, virus produced, antibody, diagnostic method and kit for detecting hhv-8 infection
08/06/1998WO1998033890A1 Human regeneration-associated serpin-1 (rasp-1) and methods of use
08/06/1998WO1998033886A1 Methods for cultivating cells and propagating viruses
08/06/1998WO1998033522A1 Infectious bursitis vaccine
08/06/1998WO1998033509A2 Useful properties of human lactoferrin and variants thereof
08/06/1998CA2595915A1 Methods for cultivating cells and propagating viruses
08/06/1998CA2279459A1 Human regeneration-associated serpin-1 (rasp-1) and methods of use
08/06/1998CA2278824A1 Infectious bursitis vaccine
08/05/1998EP0856051A1 Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof
08/05/1998CN1189857A Recombinant MVA virus, and the use thereof
08/04/1998US5789601 Method of inactivation of viral and bacterial blood contaminants
08/04/1998US5789390 Genetic enginering and vectors
08/04/1998US5789388 Vaccine against viruses associated with antibody-dependent-enhancement of viral infectivity
08/04/1998US5789231 Marek's disease vaccine
08/04/1998US5789230 Endosomolytically active particles
08/04/1998US5789194 Parasitic helminth venom allergen antigen 5-like genes and proteins
08/04/1998US5789177 Glycorproteins, antibodies, and diagnostic kits for detection of bovine herpesvirus type 1
08/04/1998US5789150 Adding sensitizer; irradiating, adding quenchers of type 1 and type 2 photodynamic reactions; no disruption of cells, or labile proteins.
08/04/1998US5788970 Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
07/1998
07/30/1998WO1998032842A1 Adenoviruses having altered hexon proteins
07/30/1998WO1998027204A3 AAV split-packaging genes and cell lines comprising such genes for use in the production of recombinant AAV vectors
07/29/1998EP0855185A2 Host-vector system for use in gene therapy
07/29/1998EP0854929A1 Recombinant viruses incorporating a protease cleavable protein
07/29/1998EP0854913A1 Method of disrupting cultured cells using an impinging jet device
07/29/1998EP0506945B1 Method of gene transfer using retrotransposons
07/29/1998CN1189104A Encapsulated cells producing viral particles
07/28/1998US5786458 Selective stabilization of protein during viral inactivation
07/28/1998US5786211 Adeno-associated virus materials and methods
07/28/1998US5786199 Genetic engineering and polymerase and rna molecules and virus sequences
07/23/1998WO1998031734A1 Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces
07/22/1998EP0854193A1 Human retroviral packaging cell line
07/22/1998EP0853666A1 Retroviral vectors pseudotyped with srv-3 envelope glycoprotein sequences
07/22/1998EP0853662A1 Novel replication competent human immunodeficiency virus type 2 (hiv-2) proviral clone designated hiv-2kr
07/22/1998EP0853660A1 Method for preserving infectious recombinant viruses, aqueous viral suspension and use as medicine
07/22/1998EP0517859B1 Oligonucleotide therapies for modulating the effects of herpesviruses
07/22/1998CN1188417A Low pathogenicity PRRS live virus vaccines and methods of preparation thereof
07/21/1998US5783195 Vaccine
07/21/1998US5783192 Recombinant feline herpesvirus vaccine
07/21/1998CA1339963C Live combination vaccine containing infectious bronchitis virus
07/16/1998WO1998030707A2 Eukaryotic gene expression cassette and uses thereof
07/16/1998WO1998030586A2 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
07/16/1998WO1998020343A3 Receptor binding assay, appropriate recombinant fusion receptor for said assay, vector for its production and reagent kit for implementing the receptor binding assay
07/16/1998CA2278326A1 Eukaryotic gene expression cassette and uses thereof
07/16/1998CA2277910A1 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
07/14/1998US5780280 Culturing a cell having an epstein barr nuclear antigen gene and an adeno-associated virus transducing vector; introducing into the cell an adeno-associated virus cap gene and rep gene; genetic engineering
07/14/1998US5780266 Feline infectious peritonitis virus diagnostic tools
07/09/1998WO1998029555A2 Cytopathic viruses for therapy and prophylaxis of neoplasia
07/09/1998WO1998029535A2 Nanoscale particles synthesized within an assembled virion
07/09/1998CA2276573A1 Nanoscale particles synthesized within an assembled virion
07/02/1998WO1998028004A1 Hepatitis delta particle containing a fusion protein immunogen
07/02/1998WO1998028000A1 Stabilizers for lyophilized vaccines
07/02/1998CA2274755A1 Stabilizers for lyophilized vaccines
07/01/1998EP0850313A2 Improved aav vectors for gene therapy
06/1998
06/30/1998US5773602 DNA fragments obtained from a novel human immunodeficiency virus designated LAVMAL
06/30/1998US5773289 AAV directed targeted integration
06/30/1998US5773267 D29 shuttle phasmids and uses thereof
06/30/1998US5773260 Ribozyme compositions and expression vectors
06/30/1998US5773009 Rotavirus strain G9P11
06/25/1998WO1998027230A1 Methods and compositions for polypeptide engineering
06/25/1998WO1998027217A1 Method for preparing retrovirus vector for gene therapy
06/25/1998WO1998027216A1 Ehv-1 vectors
06/25/1998WO1998027215A1 Live recombinant avian vaccine, using the infectious laryngotracheitis avian virus as vector
06/25/1998WO1998027208A1 NOVEL FELINE Fc EPSILON RECEPTOR ALPHA CHAIN NUCLEIC ACID MOLECULES, PROTEINS AND USES THEREOF
06/25/1998WO1998027207A1 Recombinase-activatable aav packaging cassettes for use in the production of aav vectors
06/25/1998WO1998027204A2 Aav split-packaging genes and cell lines comprising such genes for use in the production of recombinant aav vectors
06/25/1998CA2589337A1 Methods and compositions for polypeptide engineering
06/25/1998CA2275546A1 Ehv-1 vectors
06/25/1998CA2274319A1 Methods and compositions for polypeptide engineering
06/25/1998CA2270285A1 Aav split-packaging genes and cell lines comprising such genes for use in the production of recombinant aav vectors
06/25/1998CA2269661A1 Recombinase-activatable aav packaging cassettes for use in the production of aav vectors
06/24/1998EP0848757A1 The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells
06/24/1998EP0848752A1 Method for purifying viruses by chromatography
06/24/1998EP0848615A1 Multi-subtype fiv vaccines
06/24/1998CN1185811A Antigen presentation system on retrovirus-like particles
06/24/1998CN1185806A New attenuated strain of the virus causing the porcine reproductive respiratory syndrome (PRRS), vaccines and diagnostic means obtainable with said strain, and production process
06/24/1998CN1185718A Insect control with multiple toxins
06/23/1998US5770703 Nucleic acids encoding peptides of the envelope region of HIV-2 and peptides, polypeptides, and methods for producing the peptides and polypeptides of the HIV-2 envelope gene
06/23/1998US5770696 Auxiliary proteins for enhancing the insecticidal activity of pesticidal proteins
06/23/1998US5770442 Comprises a nonnative amino acid sequence which is a protease recognition sequence
06/23/1998US5770427 Retrovirus from the HIV group and its use
06/23/1998US5770356 Phagemids coexpressing a surface receptor and a surface heterologous protein
06/23/1998US5770212 Recombinant poxviruses with foreign DNA in essential regions
06/23/1998US5770211 Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
06/23/1998US5770210 Expression of htlv-iii envelope proteins by recombinant dna methods, aids vaccine
06/18/1998WO1998026075A1 Non-m non-o hiv strains, fragments and applications
06/18/1998WO1998026049A1 Recombinant equine herpesvirus type 1 (ehv-1) comprising a dysfunctional gene 71 region and use thereof as a vaccine
06/18/1998WO1998026048A1 Methods for purifying viruses
06/18/1998WO1998025646A1 Synthetic hpv16 virus-like particles
06/18/1998WO1998018950A3 AAV-DNA helper virus sequences
06/18/1998CA2274900A1 Recombinant equine herpesvirus type 1 (ehv-1) comprising a dysfunctional gene 71 region and use thereof as a vaccine
06/18/1998CA2274876A1 Method for purifying viruses
06/18/1998CA2274490A1 Non-m non-o hiv strains, fragments and applications
06/17/1998EP0847442A1 Chromatographic purification of adenovirus and aav